Global Live Attenuated Vaccine Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug, 2017 | Pages: 100 | Publisher: Data Market Research (DMR)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Live Attenuated Vaccine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Live Attenuated Vaccine market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Live Attenuated Vaccine market by By End User, By Disease Indication, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Live Attenuated Vaccine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    Astellas Pharma (Japan)
    CSL Limited (Australia)
    Emergent BioSolutions (U.S.)
    GlaxoSmithKline (U.K.)
    Johnson & Johnson (U.S.)
    MedImmune (U.S.)
    Merck & Co (U.S.)
    Pfizer (U.S.)
    Sanofi Pasteur (France)
    Serum Institute of India Pvt (India)

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Live Attenuated Vaccine Market, by End User
    Pediatrics
    Adults
Live Attenuated Vaccine Market, by Disease Indication
    Pneumococcal
    Influenza
    HPV
    Hepatitis
    Rotavirus

Live Attenuated Vaccine Market, by Key Consumer
    Hospital
    Medical Center
    Others

 Table of Contents

Global Live Attenuated Vaccine Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two Live Attenuated Vaccine Market Overview
    2.1 Market Coverage
    2.2 Global Live Attenuated Vaccine Market Sales Volume Revenue and Price 2012-2017

Chapter Three Live Attenuated Vaccine by Key Players 2012-2017
    3.1 Global Live Attenuated Vaccine Sales Volume Market Share by Key Players 2012-2017
    3.2 Global Live Attenuated Vaccine Revenue Share by Key Players 2012-2017
    3.3 Global Key Players Live Attenuated Vaccine Key Product Model and Market Performance
    3.4 Global Key Players Live Attenuated Vaccine Key Target Consumers and Market Performance

Chapter Four Live Attenuated Vaccine by Regions 2012-2017
    4.1 Global Live Attenuated Vaccine Sales Market Share by Regions 2012-2017
    4.2 Global Live Attenuated Vaccine Revenue Market Share by Regions 2012-2017
    4.3 Global Live Attenuated Vaccine Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five Live Attenuated Vaccine Market by Product Types
    5.1 Live Attenuated Vaccine, by End User 2012-2017
        5.1.1 Global Live Attenuated Vaccine Sales Market Share by End User 2012-2017
        5.1.2 Global Live Attenuated Vaccine Revenue Market Share by End User 2012-2017
        5.1.3 Global Live Attenuated Vaccine Price by End User 2012-2017
        5.1.4 Pediatrics
        5.1.5 Adults
    5.2 Live Attenuated Vaccine, by Disease Indication 2012-2017
        5.2.1 Global Live Attenuated Vaccine Sales Market Share by Disease Indication 2012-2017
        5.2.2 Global Live Attenuated Vaccine Revenue Market Share by Disease Indication 2012-2017
        5.2.3 Global Live Attenuated Vaccine Price by Disease Indication 2012-2017
        5.2.4 Pneumococcal
        5.2.5 Influenza
        5.2.6 HPV
        5.2.7 Hepatitis
        5.2.8 Rotavirus

Chapter Six Global Key Players Profile
    6.1 Astellas Pharma (Japan)
        6.1.1 Astellas Pharma (Japan) Company Details and Competitors
        6.1.2 Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
        6.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.1.4 Astellas Pharma (Japan) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.2 CSL Limited (Australia)
        6.2.1 CSL Limited (Australia) Company Details and Competitors
        6.2.2 CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
        6.2.3 CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.2.4 CSL Limited (Australia) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.3 Emergent BioSolutions (U.S.)
        6.3.1 Emergent BioSolutions (U.S.) Company Details and Competitors
        6.3.2 Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
        6.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.3.4 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.4 GlaxoSmithKline (U.K.)
        6.4.1 GlaxoSmithKline (U.K.) Company Details and Competitors
        6.4.2 GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
        6.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.4.4 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.5 Johnson & Johnson (U.S.)
        6.5.1 Johnson & Johnson (U.S.) Company Details and Competitors
        6.5.2 Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
        6.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.5.4 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.6 MedImmune (U.S.)
        6.6.1 MedImmune (U.S.) Company Details and Competitors
        6.6.2 MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
        6.6.3 MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.6.4 MedImmune (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.7 Merck & Co (U.S.)
        6.7.1 Merck & Co (U.S.) Company Details and Competitors
        6.7.2 Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
        6.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.7.4 Merck & Co (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.8 Pfizer (U.S.)
        6.8.1 Pfizer (U.S.) Company Details and Competitors
        6.8.2 Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
        6.8.3 Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.8.4 Pfizer (U.S.) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.9 Sanofi Pasteur (France)
        6.9.1 Sanofi Pasteur (France) Company Details and Competitors
        6.9.2 Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
        6.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.9.4 Sanofi Pasteur (France) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    6.10 Serum Institute of India Pvt (India)
        6.10.1 Serum Institute of India Pvt (India) Company Details and Competitors
        6.10.2 Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
        6.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
        6.10.4 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Volume Revenue Price Cost and Gross Margin

Chapter Seven Live Attenuated Vaccine by Appliance 2012-2017
    7.1 Global Live Attenuated Vaccine Sales Market Share by Appliance 2012-2017
    7.2 Hospital
    7.3 Medical Center
    7.4 Others
    7.5 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 Live Attenuated Vaccine Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 Live Attenuated Vaccine Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global Live Attenuated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    9.3 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    9.4 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    9.5 Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion

List of Tables and Figures

    Table Global Live Attenuated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
    Table Global Live Attenuated Vaccine Sales Volume Market Share by Key Players (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share by Key Players 2016
    Figure Global Live Attenuated Vaccine Sales Volume Market Share by Key Players 2017
    Table Global Live Attenuated Vaccine Revenue (Million USD) by Key Players (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by Key Players (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by Key Players 2016
    Figure Global Live Attenuated Vaccine Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Global Live Attenuated Vaccine Sales Share by Regions (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2016
    Figure Global Live Attenuated Vaccine Sales Market Share by Regions in 2017
    Table Global Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by Regions (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2016
    Figure Global Live Attenuated Vaccine Revenue Market Share by Regions in 2017
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by Regions (2012-2017)
    Table North America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table North America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Table North America Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players 2012-2017
    Figure North America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Table Latin America Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Latin America Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Europe Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Table Europe Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Europe Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Asia & Pacific Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Live Attenuated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Live Attenuated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East Live Attenuated Vaccine Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Africa & Middle East Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by End User (2012-2017)
    Table Global Live Attenuated Vaccine Sales Market Share by End User (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by End User in 2016
    Table Global Live Attenuated Vaccine Revenue (Million USD) by End User (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by End User (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by End User in 2016
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by End User (2012-2017)
    Table Top Players of Pediatrics Live Attenuated Vaccine Products List
    Figure Global Pediatrics Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Adults Live Attenuated Vaccine Products List
    Figure Global Adults Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
    Table Global Live Attenuated Vaccine Sales Market Share by Disease Indication (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Disease Indication in 2016
    Table Global Live Attenuated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by Disease Indication (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by Disease Indication in 2016
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
    Table Top Players of Pneumococcal Live Attenuated Vaccine Products List
    Figure Global Pneumococcal Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Influenza Live Attenuated Vaccine Products List
    Figure Global Influenza Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of HPV Live Attenuated Vaccine Products List
    Figure Global HPV Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Hepatitis Live Attenuated Vaccine Products List
    Figure Global Hepatitis Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Rotavirus Live Attenuated Vaccine Products List
    Figure Global Rotavirus Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by  (2012-2017)
    Table Global Live Attenuated Vaccine Sales Market Share by  (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by  in 2016
    Table Global Live Attenuated Vaccine Revenue (Million USD) by  (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by  (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by  in 2016
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by  (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by  (2012-2017)
    Table Global Live Attenuated Vaccine Sales Market Share by  (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by  in 2016
    Table Global Live Attenuated Vaccine Revenue (Million USD) by  (2012-2017)
    Table Global Live Attenuated Vaccine Revenue Market Share by  (2012-2017)
    Figure Global Live Attenuated Vaccine Revenue Market Share by  in 2016
    Table Global Live Attenuated Vaccine Price (USD/Pcs) by  (2012-2017)
    Table Astellas Pharma (Japan) Company Details and Competitors
    Table Astellas Pharma (Japan) Key Live Attenuated Vaccine Models and Performance
    Table Astellas Pharma (Japan) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Astellas Pharma (Japan) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table CSL Limited (Australia) Company Details and Competitors
    Table CSL Limited (Australia) Key Live Attenuated Vaccine Models and Performance
    Table CSL Limited (Australia) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table CSL Limited (Australia) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Emergent BioSolutions (U.S.) Company Details and Competitors
    Table Emergent BioSolutions (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (U.K.) Company Details and Competitors
    Table GlaxoSmithKline (U.K.) Key Live Attenuated Vaccine Models and Performance
    Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Johnson & Johnson (U.S.) Company Details and Competitors
    Table Johnson & Johnson (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table MedImmune (U.S.) Company Details and Competitors
    Table MedImmune (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table MedImmune (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table MedImmune (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Merck & Co (U.S.) Company Details and Competitors
    Table Merck & Co (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Merck & Co (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Merck & Co (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (U.S.) Company Details and Competitors
    Table Pfizer (U.S.) Key Live Attenuated Vaccine Models and Performance
    Table Pfizer (U.S.) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Pfizer (U.S.) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Sanofi Pasteur (France) Company Details and Competitors
    Table Sanofi Pasteur (France) Key Live Attenuated Vaccine Models and Performance
    Table Sanofi Pasteur (France) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Sanofi Pasteur (France) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Serum Institute of India Pvt (India) Company Details and Competitors
    Table Serum Institute of India Pvt (India) Key Live Attenuated Vaccine Models and Performance
    Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Business SWOT Analysis and Forecast
    Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Global Live Attenuated Vaccine Sales (K Pcs) by Appliance (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Appliance (2012-2017)
    Figure Global Live Attenuated Vaccine Sales Market Share by Appliance in 2016
    Figure Global Hospital Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Medical Center Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Others Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Live Attenuated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Share Forecast by Regions in 2022
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Application in 2022
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Live Attenuated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by End User in 2022
    Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022